Northern Trust Corp Regeneron Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 918,645 shares of REGN stock, worth $645 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

918,645

Previous 966,726 4.97%

Holding current value

$645 Million

Previous $1.02 Billion 4.95%

% of portfolio

0.16%

Previous 0.17%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1024.09 - $1201.76 $49.2 Million - $57.8 Million	-48,081 Reduced 4.97%	918,645 $966 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $21.8 Million - $26.5 Million	-24,739 Reduced 2.5%	966,726 $1.02 Billion
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $49.6 Million - $54.6 Million	-54,943 Reduced 5.25%	991,465 $954 Million
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $16.1 Million - $18.3 Million	-20,802 Reduced 1.95%	1,046,408 $919 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $23.8 Million - $29 Million	34,326 Added 3.32%	1,067,210 $878 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $85.2 Million - $101 Million	-121,689 Reduced 10.54%	1,032,884 $742 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $6.42 Million - $7.81 Million	-9,439 Reduced 0.81%	1,154,573 $949 Million
Q4 2022 Feb 13, 2023	SELL	$705.89 - $766.39 $17.5 Million - $19 Million	-24,785 Reduced 2.08%	1,164,012 $840 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $5.95 Million - $7.51 Million	-10,365 Reduced 0.86%	1,188,797 $819 Million
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $1.07 Million - $1.44 Million	-1,952 Reduced 0.16%	1,199,162 $709 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $1.32 Million - $1.54 Million	-2,212 Reduced 0.18%	1,201,114 $839 Million
Q4 2021 Feb 08, 2022	BUY	$543.48 - $670.97 $1.79 Million - $2.21 Million	3,291 Added 0.27%	1,203,326 $760 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $22.1 Million - $26.2 Million	38,532 Added 3.32%	1,200,035 $726 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $7.37 Million - $8.71 Million	-15,589 Reduced 1.32%	1,161,503 $649 Million
Q1 2021 May 12, 2021	SELL	$446.73 - $548.2 $29.4 Million - $36.1 Million	-65,883 Reduced 5.3%	1,177,092 $557 Million
Q4 2020 Feb 11, 2021	SELL	$478.3 - $607.98 $20.9 Million - $26.6 Million	-43,727 Reduced 3.4%	1,242,975 $600 Million
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $33.5 Million - $40.5 Million	61,531 Added 5.02%	1,286,702 $720 Million
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $130 Million - $170 Million	264,126 Added 27.48%	1,225,171 $764 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $4.86 Million - $7.14 Million	14,449 Added 1.53%	961,045 $469 Million
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $1.31 Million - $1.8 Million	4,771 Added 0.51%	946,596 $355 Million
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $10 Million - $11.7 Million	-36,693 Reduced 3.75%	941,825 $261 Million
Q2 2019 Aug 13, 2019	BUY	$299.6 - $414.82 $1.66 Million - $2.29 Million	5,530 Added 0.57%	978,518 $306 Million
Q1 2019 May 13, 2019	BUY	$372.08 - $439.57 $7.52 Million - $8.89 Million	20,218 Added 2.12%	972,988 $400 Million
Q4 2018 Feb 12, 2019	BUY	$335.82 - $403.04 $7.55 Million - $9.06 Million	22,468 Added 2.42%	952,770 $356 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $1.38 Million - $1.61 Million	-3,943 Reduced 0.42%	930,302 $376 Million
Q2 2018 Sep 18, 2018	SELL	$284.6 - $344.99 $1.99 Million - $2.41 Million	-6,983 Reduced 0.74%	934,245 $322 Million
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $7.09 Million - $8.6 Million	24,914 Added 2.72%	941,228 $325 Million
Q1 2018 May 09, 2018	SELL	$315.82 - $393.78 $5.97 Million - $7.44 Million	-18,895 Reduced 2.02%	916,314 $316 Million
Q4 2017 Feb 14, 2018	SELL	$358.63 - $469.95 $8.16 Million - $10.7 Million	-22,751 Reduced 2.37%	935,209 $352 Million
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $413 Million - $483 Million	957,960	957,960 $428 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Regeneron Pharmaceuticals, Inc. Transaction History